Literature DB >> 17101895

Use of the Modified Rankin Scale to assess outcome after arteriovenous malformation radiosurgery.

Bruce E Pollock1, Robert D Brown.   

Abstract

OBJECTIVE: To present the results of arteriovenous malformation (AVM) radiosurgery using the Modified Rankin Scale (MRS) as the primary outcome measure and to analyze whether previous AVM rupture or other factors have an effect on outcomes after AVM radiosurgery.
METHODS: We reviewed outcomes after AVM radiosurgery for 243 patients from 1990 and 2001. The mean follow-up after radiosurgery was 65 months.
RESULTS: Forty-one patients (17%) sustained a decline in MRS (median -2) after AVM radiosurgery. We noted a decline in MRS in 4% of patients 1 year after radiosurgery, 8% of patients at 3 years after radiosurgery, and 15% of patients at 7 years after radiosurgery. The radiosurgery-based AVM score correlated with a decline in MRS after AVM radiosurgery in multivariate testing (odds ratio 2.1; 95% CI 1.2 to 3.6; p < 0.01).
CONCLUSIONS: Previous AVM rupture did not influence neurologic deterioration after AVM radiosurgery. The radiosurgery-based AVM score predicted the chance of a worse MRS after radiosurgery.

Entities:  

Mesh:

Year:  2006        PMID: 17101895     DOI: 10.1212/01.wnl.0000242738.60683.dd

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Predictability and uncertainty in arteriovenous malformation radiosurgery.

Authors:  Bruce E Pollock
Journal:  J Radiosurg SBRT       Date:  2013

2.  The rationale behind "A Randomized Trial of Unruptured Brain AVMs" (ARUBA).

Authors:  Christian Stapf
Journal:  Acta Neurochir Suppl       Date:  2010

3.  Diagnosis and evaluation of intracranial arteriovenous malformations.

Authors:  Andrew Conger; Charles Kulwin; Michael T Lawton; Aaron A Cohen-Gadol
Journal:  Surg Neurol Int       Date:  2015-05-12

4.  Utility of modified Rankin Scale for brain vascular malformations in hereditary hemorrhagic telangiectasia.

Authors:  K P Thompson; J Nelson; H Kim; S M Weinsheimer; D A Marchuk; M T Lawton; T Krings; M E Faughnan
Journal:  Orphanet J Rare Dis       Date:  2021-09-19       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.